The long-term objective of this proposal is to uncover mechanisms involved in the regulation of HNSCC pathogenesis and therapy. Human (dihydro)ceramide syntheses 1-6, (dh)CerS1-6, identified as yeast homologues of the longevity assurance gene 1-6 (LASS1-6) regulate the de novo generation of endogenous ceramides with specific fatty acid chain lengths;for example, whereas (dh)CerS1/LASS1 is responsible for the generation of C18-(dihydro)ceramide, (dh)CerS6/LASS6 generates C16-(dihydro)ceramide. These dihydroceramides are then desaturated to ceramides (with their distinct fatty acid chain lengths) by dihydroceramide desaturase (Des). In the cell, these two enzymatic steps (dihydroceramide synthesis and desaturation) occur in the endoplasmic reticulum (ER). Remarkably, our ongoing mechanistic studies reveal that knock down of LASS6/C16-(dihydro)ceramide induces ER stress, which then triggers mitochondrial apoptosis in HNSCC cells. In addition, treatment of HNSCC cells with known ER stress inducers, such as tunicamycin, results in a rapid degradation of LASS6 protein prior to apoptosis. More importantly, increased levels of C16-ceramide via induction of hl_ASS6 expression enhance resistance, and protect HNSCC cells from ER stress and cell death. Collectively, these data suggest a novel hypothesis that LASSS-generated C16-(dihydro)ceramide plays important roles in the regulation of ER homeostasis, such that down-regulation of this pathway mediates a significant component of the ER stress response, which then leads to apoptosis in HNSCC cells. To test this novel hypothesis, three Specific Aims are proposed: 1) Determine the roles of LASS6/C16-(dihydro)ceramide in the regulation of ER stress in HNSCC cells;2) Identify the mechanisms by which down-regulation of LASS6/C16-(dihydro)ceramide induces ER stress (or a component of the stress), and consequent apoptosis in HNSCC cells;and 3) Establish the in vivo roles and clinical relevance of LASS6/C16-(dihydro)ceramide in HNSCC pathogenesis and/or response to therapy via the regulation of ER stress. Thus, these studies will help determine the roles and mechanisms of action of LASS6/C16- (dihydro)ceramide in the regulation of ER stress in HNSCC cells. Importantly, these results have tremendous implications in unraveling the complexities of ceramide signaling and ER stress, in addition to clear therapeutic implications that will be defined in this proposal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
7P01CA097132-10
Application #
8381029
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
10
Fiscal Year
2012
Total Cost
$162,715
Indirect Cost
$31,551
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Hannun, Yusuf A; Obeid, Lina M (2018) Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol 19:175-191
Schwartz, Nicholas U; Linzer, Ryan W; Truman, Jean-Philip et al. (2018) Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F. FASEB J 32:1716-1728
Moorthi, Sitapriya; Burns, Tara Ann; Yu, Gui-Qin et al. (2018) Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation. FASEB J 32:4270-4283
Morris, Thomas G; Borland, Samantha J; Clarke, Christopher J et al. (2018) Sphingosine 1-phosphate activation of ERM contributes to vascular calcification. J Lipid Res 59:69-78
Coant, Nicolas; García-Barros, Mónica; Zhang, Qifeng et al. (2018) AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells. Oncogene 37:3852-3863
Ren, Jihui; Snider, Justin; Airola, Michael V et al. (2018) Quantification of 3-ketodihydrosphingosine using HPLC-ESI-MS/MS to study SPT activity in yeast Saccharomyces cerevisiae. J Lipid Res 59:162-170
Shimizu, Yoshiko; Furuya, Hideki; Tamashiro, Paulette M et al. (2018) Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model. Carcinogenesis 39:47-55
Carroll, Brittany L; Bonica, Joseph; Shamseddine, Achraf A et al. (2018) A role for caspase-2 in sphingosine kinase 1 proteolysis in response to doxorubicin in breast cancer cells - implications for the CHK1-suppressed pathway. FEBS Open Bio 8:27-40
Xu, Ruijuan; Garcia-Barros, Monica; Wen, Sally et al. (2018) Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2. Cell Death Differ 25:841-856
Coant, Nicolas; Hannun, Yusuf A (2018) Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer. Adv Biol Regul :

Showing the most recent 10 out of 215 publications